Migraines
17
2
2
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
93.3%
+6.8% vs benchmark
18%
3 trials in Phase 3/4
29%
4 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (17)
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Mind Body Intervention for Chronic Migraine Headaches
Quantitative Sensory Testing and Occipital Nerve Stimulator
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250
Pain Processing in Adults With Migraines
Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines
Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients
A Study of LY2951742 in Healthy Volunteers
Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
A Nutritional Intervention for Migraines-2
Integrative Coping Group for Children
A Nutritional Intervention for Migraines
Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals
A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.